28 May 2024 | Statements

Unitaid joins the Triple I for Global Health to strengthen global health impact investments

Unitaid is proud to announce its partnership with the Impact Investment Initiative for Global Health (Triple I for GH). This strategic move underscores Unitaid’s commitment to innovative financing solutions that address critical health challenges in low- and middle-income countries. Unitaid joined Triple I for GH today at an event during the World Health Assembly, alongside Japan Ambassador Hideo Suzuki and Triple I co-chairs Ken Shibusawa, Dr. Ayoade Alakja and Steve Davis.

“We welcome the participation of Unitaid in the Triple I Initiative,” said H.E Mr. Hideo Suzuki, Ambassador for Public Diplomacy and Ambassador for Global Health, Cabinet Secretariat of Japan. “The financial burden of global health has been increasing, especially in low- and middle-income countries. Against this background, the mobilization of private capital through sustainable financing as well as public finance is fundamental in achieving the SDGs by 2030.”

The Triple I for GH, launched at the margin of United Nations General Assembly High-level Meetings in September 2023, is a groundbreaking initiative endorsed by the G7 leaders at the Hiroshima Summit in 2023 that aims to mobilize private capital alongside public finance to support sustainable financing in global health. This initiative is essential to help achieve the Sustainable Development Goals (SDGs) by 2030, particularly in enhancing universal health coverage and pandemic prevention, preparedness and response.

“Unitaid is honored to join the Triple I initiative, a landmark effort spearheaded by Japan to leverage impact investment for global health,” said Philippe Duneton, Unitaid’s Executive Director. “This partnership aligns with our mission to introduce innovative, affordable health solutions and take them to scale for those in need. By mobilizing private capital alongside public funds, we can accelerate progress towards universal health coverage and strengthen pandemic preparedness.”

Unitaid has a long-standing history of improving access to treatment, diagnostics, and prevention for major diseases such as HIV, tuberculosis, and malaria. As part of the Triple I initiative, Unitaid will join more than 70 other global health organizations and private sector companies to foster impactful investments that generate measurable social and environmental benefits, alongside financial returns.

“Our aim is to raise awareness and share best practices on impact investment in global health to attract new forms of private sector capital,” said Shibusawa. “Partners of Triple I for GH can demonstrate globally their endeavors to improve access to health for people in low- and middle-income countries, to solve global health issues, and contribute to a more sustainable world while increasing their corporate value. We look forward to collaborating with Unitaid on this important initiative.”

Triple I for GH promotes projects that address global health issues in low- and middle-income countries, focusing on increasing access to and affordability of health services and products. Key target areas include communicable diseases such as HIV, tuberculosis, and malaria; non-communicable diseases, including mental health conditions; sexual and reproductive health and rights; maternal, newborn, child, and adolescent health; pandemic preparedness and health system strengthening; and innovative products and technologies like diagnostics, vaccines, and digital health solutions.

View All News

Featured News

27 May 2024

PAHO and Unitaid strengthen partnership to eliminate communicable diseases from the Americas

Read More

23 May 2024

Countdown to 2030: Stronger alignment for country impact

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.